New progesterone receptor antagonists: 3,3-disubstituted-5-aryloxindoles

A new series of 3,3-disubstituted-5-aryloxindoles has been synthesized and evaluated for progesterone receptor antagonist (PR) activity in a T47D cell alkaline phosphatase assay and for their ability to bind PR in competition binding studies. In this communication, the synthesis and structure–activi...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters Vol. 12; no. 23; pp. 3487 - 3490
Main Authors: Fensome, Andrew, Bender, Reinhold, Cohen, Jeffrey, Collins, Mark A., Mackner, Valerie A., Miller, Lori L., Ullrich, John W., Winneker, Richard, Wrobel, Jay, Zhang, Puwen, Zhang, Zhiming, Zhu, Yuan
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 02-12-2002
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A new series of 3,3-disubstituted-5-aryloxindoles has been synthesized and evaluated for progesterone receptor antagonist (PR) activity in a T47D cell alkaline phosphatase assay and for their ability to bind PR in competition binding studies. In this communication, the synthesis and structure–activity relationships (SARs) of various 3,3-substituents are discussed where it is clear that small alkyl and spiroalkyl groups are required to achieve better PR antagonist activity. The synthesis and SARs of a novel series of progesterone receptor antagonists 4 based upon a 5-aryl oxindole platform are discussed.
ISSN:0960-894X
1464-3405
DOI:10.1016/S0960-894X(02)00746-1